Login to your account

Lost your password?

Five stocks to buy on the big dip

Pfizer (PFE)

I first identified Pfizer as a buy a few months back, noting that that generic availability of its most famous drug, Viagra, was going to have little negative impact of the company’s health, given its extremely robust pipeline. (The company is expecting 25 to 30 key regulatory approvals over the next five years.) Since then, things have been great for the company and the stock, until, beginning last week, shares took a nosedive, falling all the way from $39 and change to under $35. Given that the strength is still there, this could be the perfect time to buy.


Chart courtesy of www.stockcharts.com

Symbols: , , , ,

Julian Close

Julian Close became a stockbroker in 1995. In his 20 years of market experience, he has seen all market conditions and written about every aspect of investing. Julian has also written extensively on corporate best practices and even written reports for the United Nations. He graduated from Davidson College in 1993 and received a Master of Arts in Teaching from Mary Baldwin College in 2011. You can see closing trades for all Julian's long and short positions and track his long term performance via twitter: @JulianClose_MIC.